We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
AUM
$46M
AUM Growth
-$425K
Cap. Flow
+$24.7K
Cap. Flow %
0.05%
Top 10 Hldgs %
40.01%
Holding
34
New
Increased
9
Reduced
15
Closed

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$15.1K
2
JNJ icon
Johnson & Johnson
JNJ
+$12.5K
3
BMY icon
Bristol-Myers Squibb
BMY
+$12.2K
4
INTC icon
Intel
INTC
+$11.9K
5
IBM icon
IBM
IBM
+$11K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.07K
2
VYX icon
NCR Voyix
VYX
+$8.45K
3
GILD icon
Gilead Sciences
GILD
+$8.12K
4
FLR icon
Fluor
FLR
+$6.54K
5
MKL icon
Markel Group
MKL
+$5.65K

Sector Composition

Rank Sector Weight
1 Financials 24.87%
2 Healthcare 22.49%
3 Technology 17.59%
4 Consumer Staples 10.78%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
1
Wells Fargo
WFC
$261B
$3.53M 7.68%
63,656
-40
-0.1% -$2.14K
RIO icon
2
Rio Tinto
RIO
$158B
$1.91M 4.15%
34,400
-40
-0.1% -$2.24K
MSFT icon
3
Microsoft
MSFT
$3.45T
$1.77M 3.85%
17,940
-25
-0.1% -$2.42K
IBM icon
4
IBM
IBM
$211B
$1.75M 3.82%
13,139
+79
+0.6% +$11K
T icon
5
AT&T
T
$159B
$1.74M 3.79%
71,794
+152
+0.2% +$3.81K
GILD icon
6
Gilead Sciences
GILD
$162B
$1.56M 3.39%
22,015
-115
-0.5% -$8.12K
UNH icon
7
UnitedHealth
UNH
$376B
$1.54M 3.35%
6,272
-10
-0.2% -$2.4K
INTC icon
8
Intel
INTC
$455B
$1.53M 3.34%
30,886
+225
+0.7% +$11.9K
BAC icon
9
Bank of America
BAC
$435B
$1.53M 3.33%
54,336
JPM icon
10
JPMorgan Chase
JPM
$935B
$1.52M 3.31%
14,618
ELV icon
11
Elevance Health
ELV
$81.5B
$1.48M 3.22%
6,215
FLR icon
12
Fluor
FLR
$7.01B
$1.42M 3.08%
29,055
-125
-0.4% -$6.54K
MKL icon
13
Markel Group
MKL
$23.3B
$1.4M 3.05%
1,295
-5
-0.4% -$5.65K
HON icon
14
Honeywell
HON
$77B
$1.39M 3.02%
10,678
-17
-0.2% -$2.26K
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.39M 3.02%
7,440
-20
-0.3% -$3.9K
DEO icon
16
Diageo
DEO
$49B
$1.32M 2.88%
9,182
ABBV icon
17
AbbVie
ABBV
$443B
$1.31M 2.84%
14,092
ABT icon
18
Abbott
ABT
$183B
$1.29M 2.8%
21,132
KMB icon
19
Kimberly-Clark
KMB
$36.3B
$1.27M 2.77%
12,083
CVX icon
20
Chevron
CVX
$392B
$1.27M 2.76%
10,040
JNJ icon
21
Johnson & Johnson
JNJ
$618B
$1.26M 2.75%
10,410
+100
+1% +$12.5K
EMR icon
22
Emerson Electric
EMR
$83.9B
$1.22M 2.66%
17,705
-30
-0.2% -$2.11K
PFE icon
23
Pfizer
PFE
$143B
$1.11M 2.42%
32,321
+264
+0.8% +$9.02K
AAPL icon
24
Apple
AAPL
$4.54T
$1.09M 2.38%
23,624
-200
-0.8% -$9.07K
AON icon
25
Aon
AON
$76.5B
$1.03M 2.25%
7,525

Similar funds

Needelman Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Needelman Asset Management held 34 positions worth $46M, down 0.92% from $46.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 0%. Needelman Asset Management opened no new positions and made no exits, leaving the 34-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

  • Needelman Asset Management added most to Procter & Gamble in Q2 2018, an estimated $15.1K increase.
  • Needelman Asset Management's biggest Q2 2018 reduction was Apple, cutting an estimated $9.07K.
  • Needelman Asset Management's ten largest holdings make up 40% of its $46M portfolio in Q2 2018.
  • Needelman Asset Management opened 0 new positions and closed 0 in Q2 2018.
  • Needelman Asset Management's portfolio value fell 0.92% quarter-over-quarter to $46M.

Based on Needelman Asset Management's 13F filing for Q2 2018, filed 10 Jul 2018.